Temozolomide in uterine leiomyosarcomas Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Leiomyosarcoma
  • Uterine Neoplasms

abstract

  • Temozolomide has promising therapeutic benefit and is well tolerated in patients with metastatic unresectable leiomyosarcoma. Further investigation of temozolomide in leiomyosarcoma patients is warranted.

publication date

  • July 2005

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2005.03.018

PubMed ID

  • 15916799

Additional Document Info

start page

  • 99

end page

  • 103

volume

  • 98

number

  • 1